- Home
- IXHL vs GCTS Comparison
IXHL vs GCTS Comparison
Compare IXHL & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- GCTS
- Stock Information
- Founded
- IXHL 2001
- GCTS 1998
- Country
- IXHL Australia
- GCTS United States
- Employees
- IXHL N/A
- GCTS N/A
- Industry
- IXHL
- GCTS Blank Checks
- Sector
- IXHL
- GCTS Finance
- Exchange
- IXHL Nasdaq
- GCTS Nasdaq
- Market Cap
- IXHL 78.7M
- GCTS 82.5M
- IPO Year
- IXHL N/A
- GCTS N/A
- Fundamental
- Price
- IXHL $1.05
- GCTS $1.54
- Analyst Decision
- IXHL
- GCTS Strong Buy
- Analyst Count
- IXHL 0
- GCTS 1
- Target Price
- IXHL N/A
- GCTS $5.00
- AVG Volume (30 Days)
- IXHL 163.0M
- GCTS 337.9K
- Earning Date
- IXHL 05-15-2025
- GCTS 08-13-2025
- Dividend Yield
- IXHL N/A
- GCTS N/A
- EPS Growth
- IXHL N/A
- GCTS N/A
- EPS
- IXHL N/A
- GCTS N/A
- Revenue
- IXHL $98,000.00
- GCTS $6,359,000.00
- Revenue This Year
- IXHL $2,538.49
- GCTS $133.55
- Revenue Next Year
- IXHL $249.95
- GCTS $347.37
- P/E Ratio
- IXHL N/A
- GCTS N/A
- Revenue Growth
- IXHL N/A
- GCTS N/A
- 52 Week Low
- IXHL $0.08
- GCTS $0.90
- 52 Week High
- IXHL $3.12
- GCTS $5.01
- Technical
- Relative Strength Index (RSI)
- IXHL 65.21
- GCTS 57.29
- Support Level
- IXHL $0.21
- GCTS $1.32
- Resistance Level
- IXHL $1.66
- GCTS $1.69
- Average True Range (ATR)
- IXHL 0.15
- GCTS 0.09
- MACD
- IXHL 0.11
- GCTS 0.01
- Stochastic Oscillator
- IXHL 57.99
- GCTS 62.50
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.